Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

1 terminated/withdrawn out of 69 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

13%

9 trials in Phase 3/4

Results Transparency

0%

0 of 18 completed trials have results

Key Signals

11 recruiting

Enrollment Performance

Analytics

Phase 2
15(35.7%)
N/A
14(33.3%)
Phase 4
7(16.7%)
Early Phase 1
2(4.8%)
Phase 1
2(4.8%)
Phase 3
2(4.8%)
42Total
Phase 2(15)
N/A(14)
Phase 4(7)
Early Phase 1(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (69)

Showing 20 of 69 trials
NCT06686355Phase 2Recruiting

The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula

Role: lead

NCT06018181Completed

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

Role: lead

NCT06703671Not ApplicableRecruiting

Electroacupuncture Treatment for Discogenic Low Back Pain

Role: collaborator

NCT07342075Recruiting

Registry Study of Cerebral Small Vessel Disease

Role: lead

NCT07250035Phase 3Not Yet Recruiting

Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy

Role: collaborator

NCT07271732Not ApplicableNot Yet Recruiting

Songling Xuemaikang Capsules for Cerebral Small Vessel Disease

Role: lead

NCT06857487Phase 1Recruiting

Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke

Role: lead

NCT07163702Phase 2Not Yet Recruiting

Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke

Role: lead

NCT07139639Early Phase 1Not Yet Recruiting

Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease

Role: collaborator

NCT06933238Phase 1Not Yet Recruiting

Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis

Role: lead

NCT06655389Recruiting

Correlation Between PLA Levels and Disease Severity in Patients With Sepsis Cardiac Insufficiency

Role: lead

NCT06612216Not Yet Recruiting

Establishment of Cohort Under the Guidance of the Pathogenesis of Cancer Toxin in Traditional Chinese Medicine

Role: collaborator

NCT06606522Completed

A Clinical Diagnostic System for Intrinsic Acute Kidney Disease

Role: collaborator

NCT06470477Not Yet Recruiting

Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke

Role: lead

NCT05626296Recruiting

Molecular Network Characteristics of Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics Integrated Analysis

Role: lead

NCT05833932Recruiting

Suhexiang Pill for Acute Ischemic Stroke: A Registry Study

Role: lead

NCT06320249Not ApplicableNot Yet Recruiting

Rotation-traction Manipulation of Different Treatment Frequency in Cervical Radiculopathy

Role: collaborator

NCT05978089Phase 4Unknown

Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY)

Role: lead

NCT03041987Active Not Recruiting

Chinese Cohort Study of Chronic Kidney Disease

Role: collaborator

NCT03571451Unknown

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform

Role: collaborator